Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement

Abstract

Colorectal cancer (CRC) still remains a disease with high percentage of death, principally due to therapy resistance and metastasis. During the time the hypothesis has been reinforced that CRC stem cells (CRCSC) are involved in allowing intratumoral heterogeneity, drug escape mechanisms and secondary tumors. CRCSC are characterized by specific surface markers (i.e., CD44 and CD133), signaling pathways activation (i.e., Wnt and Notch) and gene expression (i.e., Oct4 and Snail), which confer to CRCSC self-renewal abilities and pluripotent capacity. Interleukin (IL)-8 is correlated to CRC progression, development of liver metastases and chemoresistance; moreover, IL-8 modulates not only stemness maintenance but also stemness promotion, such as epithelial-mesenchymal transition. This review wants to give a brief and up-to-date overview on IL-8 implication in CRCSC cues.

Keywords

Interleukin-8 / colorectal cancer / cancer stem cells / tumor microenvironment

References

[1] Hammond WA,Mody K.Pharmacologic resistance in colorectal cancer: a review..Ther Adv Med Oncol2016;8:57-84 PMCID:PMC4699262

[2] Zeuner A,Stassi G.Colorectal cancer stem cells: from the crypt to the clinic..Cell Stem Cell2014;15:692-705

[3] Todaro M,Medema JP.Colon cancer stem cells: promise of targeted therapy..Gastroenterology2010;138:2151-62

[4] Chen K,Chen JL.Understanding and targeting cancer stem cells: therapeutic implications and challenges..Acta Pharmacol Sin2013;34:732-40 PMCID:PMC3674516

[5] Plaks V,Werb Z.The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?.Cell Stem Cell2015;16:225-38 PMCID:PMC4355577

[6] Das M.Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence..Int J Biochem Cell Biol2018;103:115-24

[7] Barker N.Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration..Nat Rev Mol Cell Biol2014;15:19-33

[8] Cabarcas SM,Farrar WL.The cancer stem cell niche--there goes the neighborhood?.Int J Cancer2011;129:2315-27

[9] Wu XB,Wang GH,Cai Y.Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-kappaB activation..Sci Rep2016;6:21420 PMCID:PMC4759824

[10] Bazzichetto C,Falcone I,Milella M.Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer..J Oncol2019;2019:5373580 PMCID:PMC6525927

[11] Liu Q,Tian Y,Liu Y.The CXCL8-CXCR1/2 pathways in cancer..Cytokine Growth Factor Rev2016;31:61-71 PMCID:PMC6142815

[12] Ning Y,Zhang W,Gerger A.The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models..Mol Cancer Ther2012;11:1353-64

[13] Brabletz T,Spaderna S,Kirchner T.Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression..Nat Rev Cancer2005;5:744-9

[14] Gao W,Ma Z,Zhao Z.Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential..Gastroenterology2013;145:636-46.e5

[15] Pan T,Zhu Y.Self-renewal molecular mechanisms of colorectal cancer stem cells..Int J Mol Med2017;39:9-20 PMCID:PMC5179189

[16] O’Brien CA,Ryan P,Gibson L.ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21..Cancer Cell2012;21:777-92

[17] Kreso A,Pedley NM,Frelin C.Self-renewal as a therapeutic target in human colorectal cancer..Nat Med2014;20:29-36

[18] Shang S,Hu ZW.The regulation of beta-catenin activity and function in cancer: therapeutic opportunities..Oncotarget2017;8:33972-89 PMCID:PMC5464927

[19] Rich JN.Cancer stem cells: understanding tumor hierarchy and heterogeneity..Medicine (Baltimore)2016;95:S2-7 PMCID:PMC5599210

[20] Zhou Y,Wang H,Su M.Cancer stem cells in progression of colorectal cancer..Oncotarget2018;9:33403-15 PMCID:PMC6161799

[21] Li Z.CD133: a stem cell biomarker and beyond..Exp Hematol Oncol2013;2:17 PMCID:PMC3701589

[22] O’Brien CA,Gallinger S.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice..Nature2007;445:106-10

[23] Ricci-Vitiani L,Pilozzi E,Todaro M.Identification and expansion of human colon-cancer-initiating cells..Nature2007;445:111-5

[24] Kazama S,Kiyomatsu T,Nozawa H.Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis..Asian J Surg2018;41:274-8

[25] Shmelkov SV,Hooper AT,Kushner J.CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors..J Clin Invest2008;118:2111-20 PMCID:PMC2391278

[26] Ozawa M,Zheng YW,Miyata H.Prognostic significance of CD44 variant 2 upregulation in colorectal cancer..Br J Cancer2014;111:365-74 PMCID:PMC4102936

[27] Todaro M,Catalano V,Iovino F.CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis..Cell Stem Cell2014;14:342-56

[28] Saito S,Watanabe M,Iwatsuki M.CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer..Oncol Rep2013;29:1570-8

[29] Zhao LH,Wei J,Wang KJ.CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression..Int J Clin Exp Pathol2015;8:692-701 PMCID:PMC4348888

[30] Jing F,Kim CH,Lee JH.Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases..Int J Oncol2015;46:1582-8

[31] Wang C,Guo J,Gore JC.Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer..Oncol Rep2012;28:1301-8 PMCID:PMC3981033

[32] Levin TG,Davies PS,Dismuke AD.Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract..Gastroenterology2010;139:2072-82.e5 PMCID:PMC2997177

[33] Swart GW.Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration..Eur J Cell Biol2002;81:313-21

[34] Dalerba P,Park IK,Wang X.Phenotypic characterization of human colorectal cancer stem cells..Proc Natl Acad Sci U S A2007;104:10158-63 PMCID:PMC1891215

[35] Tachezy M,Gebauer F,Kaifi JT.Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients..J Surg Res2012;177:e15-20

[36] Liu D,Zhu J,Zhang X.Expression and clinical significance of colorectal cancer stem cell marker EpCAM(high)/CD44(+) in colorectal cancer..Oncol Lett2014;7:1544-8 PMCID:PMC3997707

[37] Nagrath S,Maheswaran S,Irimia D.Isolation of rare circulating tumour cells in cancer patients by microchip technology..Nature2007;450:1235-9 PMCID:PMC3090667

[38] Trzpis M,de Leij LM.Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule..Am J Pathol2007;171:386-95 PMCID:PMC1934518

[39] Lin CW,Lin WW,Lu TY.Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer..J Biol Chem2012;287:39449-59 PMCID:PMC3501065

[40] Leng Z,Chen J,Xu J.Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer..Cell Physiol Biochem2018;46:860-72

[41] Barker N,Kuipers J,van den Born M.Identification of stem cells in small intestine and colon by marker gene Lgr5..Nature2007;449:1003-7

[42] Van der Flier LG,Oving I,De Palo M.The Intestinal Wnt/TCF Signature..Gastroenterology2007;132:628-32

[43] de Lau W,Low TY,Li VS.Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling..Nature2011;476:293-7

[44] Uchida H,Fukuma M,Hayashida T.Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer..Cancer Sci2010;101:1731-7

[45] Hsu HC,Tseng KC,Liang Y.Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer..Int J Colorectal Dis2013;28:1535-46

[46] Huang EH,Zhang T,Dontu G.Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis..Cancer Res2009;69:3382-9 PMCID:PMC2789401

[47] Kozovska Z,Bajzik V,Demkova L.ALDH1A inhibition sensitizes colon cancer cells to chemotherapy..BMC Cancer2018;18:656 PMCID:PMC6003038

[48] Hessman CJ,Billingsley KG,Wong MH.Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer..Am J Surg2012;203:649-53 PMCID:PMC4285581

[49] Nakanishi Y,Fukuoka A,Yamaga Y.Dclk1 distinguishes between tumor and normal stem cells in the intestine..Nat Genet2013;45:98-103

[50] Chandrakesan P,Qu D,Weygant N.Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells..Mol Cancer2017;16:30 PMCID:PMC5286867

[51] Mohammadi Y,Saidijam M,Etemadi K.DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c..Biomed Pharmacother2018;103:301-7

[52] Li L,Mei H.Doublecotin-like kinase 1 increases chemoresistance of colorectal cancer cells through the anti-apoptosis pathway..J Stem Cell Res Ther2019;9:447 PMCID:PMC6671676

[53] Vermeulen L,van der Heijden M,de Jong JH.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment..Nat Cell Biol2010;12:468-76

[54] Li HJ,Herschman HR.Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling..Cancer Discov2012;2:840-55 PMCID:PMC3833451

[55] Lu J,Fan F,Bhattacharya R.Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1..Cancer Cell2013;23:171-85 PMCID:PMC3574187

[56] Lotti F,Pai RK,Lathia J.Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A..J Exp Med2013;210:2851-72 PMCID:PMC3865474

[57] Conciatori F,Falcone I,Bria E.Role of mTOR Signaling in Tumor Microenvironment: An Overview..Int J Mol Sci2018;19:E2453 PMCID:PMC6121402

[58] Kryczek I,Nagarsheth N,Zhao L.IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L..Immunity2014;40:772-84 PMCID:PMC4032366

[59] David JM,Hamilton DH.The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance..Vaccines (Basel)2016;4:E22 PMCID:PMC5041016

[60] Long X,Zhang L,Yu W.IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)..Int J Oncol2016;48:5-12

[61] Wang J,Wang S,Shi J.Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer..Oncotarget2015;6:42825-37 PMCID:PMC4767474

[62] Hwang WL,Tsai ML,Su SH.SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells..Gastroenterology2011;141:279-91.e5

[63] Hwang WL,Cheng WC,Yang MH.Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer..J Hematol Oncol2019;12:10 PMCID:PMC6347849

[64] Roncucci L,Mariani F,Pezzi A.Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk..Cancer Epidemiol Biomarkers Prev2008;17:2291-7

[65] Droeser RA,Eppenberger-Castori S,Viehl CT.High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor..PLoS One2013;8:e64814 PMCID:PMC3667167

[66] Luo CW,Wang JY,Hung WC.Cell Motility Facilitated by Mono(2-ethylhexyl) Phthalate via Activation of the AKT-beta-Catenin-IL-8 Axis in Colorectal Cancer..J Agric Food Chem2018;66:9635-44

[67] Chang CJ,Lu KH,Chou YC.Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells..Biochem Biophys Res Commun2011;415:245-51

[68] Carpentino JE,Appelman HD,Steindler DA.Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer..Cancer Res2009;69:8208-15 PMCID:PMC2776663

[69] Fisher RC,Alex Molina L,Liska D.Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells..Neoplasia2019;21:269-81 PMCID:PMC6370871

[70] Fang S.Advances in glucose metabolism research in colorectal cancer..Biomed Rep2016;5:289-95 PMCID:PMC4998148

[71] Shimizu M.IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells..Oncogene2019;38:1520-33

[72] Jiang M,Li X,Chu Y.O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit..Oncogene2019;38:301-16 PMCID:PMC6336687

[73] Long J,Zhu N,Yin YF.Lipid metabolism and carcinogenesis, cancer development..Am J Cancer Res2018;8:778-91 PMCID:PMC5992506

[74] Ocvirk S.Influence of Bile Acids on Colorectal Cancer Risk: Potential Mechanisms Mediated by Diet - Gut Microbiota Interactions..Curr Nutr Rep2017;6:315-22 PMCID:PMC5802424

[75] Nguyen TT,Kim NH.Role of bile acids in colon carcinogenesis..World J Clin Cases2018;6:577-88 PMCID:PMC6232560

[76] Nguyen TT,Ung TT,Han JY.Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity..J Cell Biochem2017;118:2958-67